Accessibility Menu
Strata Skin Sciences Stock Quote

Strata Skin Sciences (NASDAQ: SSKN)

$1.63
(-3.5%)
-0.06
Price as of October 22, 2025, 3:50 p.m. ET

KEY DATA POINTS

Current Price
$1.63
Daily Change
(-3.5%) $0.06
Day's Range
$1.53 - $1.68
Previous Close
$1.63
Open
$1.66
Beta
0.30
Volume
1,019
Average Volume
4,459,073
Market Cap
9.3M
Market Cap / Employee
$1.63M
52wk Range
$1.38 - $3.86
Revenue
-
Gross Margin
0.58%
Dividend Yield
N/A
EPS
-$2.78
CAPs Rating
-
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Strata Skin Sciences Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
SSKN-45.85%-88.36%-34.96%-100%
S&P+14.5%+93.32%+14.09%+459%

Strata Skin Sciences Company Info

STRATA Skin Sciences, Inc. is a medical technology company in Dermatology and Plastic Surgery. It engages in developing, commercializing and marketing products for the treatment of dermatologic conditions. The firm operates through the following segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. The Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. The company was founded by Dina Gutkowicz-Krusin in December 1989 and is headquartered in Horsham, PA.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$7.66M-9.2%
Gross Profit$4.31M-12.9%
Gross Margin56.19%-2.4%
Market Cap$9.55M-11.3%
Market Cap / Employee$0.09M0.0%
Employees1067.1%
Net Income-$2.49M-2414.1%
EBITDA-$0.92M-208.2%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$5.97M-12.5%
Accounts Receivable$4.02M1.1%
Inventory3.220.2%

Liabilities

Q2 2025YOY Change
Long Term Debt$16.05M-0.9%
Short Term Debt$0.30M-3.2%

Ratios

Q2 2025YOY Change
Return On Assets-32.83%-15.3%
Return On Invested Capital-25.85%-7.0%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$1.88M-864.2%
Operating Free Cash Flow-$1.94M-428.4%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book1.021.302.213.58213.61%
Price to Sales0.340.360.330.29-11.57%
Price to Tangible Book Value-2.87-4.02-3.63-1.97-28.35%
Enterprise Value to EBITDA-57.6221.08-27.55-21.70-190.05%
Return on Equity-73.5%-114.2%-151.2%-235.4%273.83%
Total Debt$16.48M$16.44M$16.40M$16.35M-0.95%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.